Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients

Lignende værker

• Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset
  af: Ravelli, A, et al.
  Udgivet: (2014)
• Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
  af: Ravelli, A, et al.
  Udgivet: (2014)
• Predictors of response in patients with active systemic JIA (SJIA) receiving canakinumab: an exploratory analysis of pooled 12-week data
  af: Ruperto, N, et al.
  Udgivet: (2014)
• Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
  af: Horneff, G, et al.
  Udgivet: (2015)
• PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
  af: Quartier, P, et al.
  Udgivet: (2013)